The druggable genome

Nature Reviews Drug Discovery

Volumn 1, Issue 9, 2002, Pages 727-730

  Hopkins, Andrew L ^a   Groom, Colin R ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA VACCINE; G PROTEIN COUPLED RECEPTOR; HORMONE RECEPTOR; METALLOPROTEINASE; PHOSPHODIESTERASE; PROTEIN DERIVATIVE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SERINE PROTEINASE;

ARTICLE; DRUG BINDING SITE; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG TARGETING; GENE TARGETING; HUMAN; MEDICAL RESEARCH; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN FAMILY; BIOAVAILABILITY; CHEMISTRY; DRUG EFFECT; GENOME; MOLECULAR BIOLOGY; PHARMACOKINETICS;

BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; GENOME, HUMAN; HUMANS; MOLECULAR BIOLOGY; PHARMACOKINETICS;

EID: 0036717194     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd892     Document Type: Article

References (16)

1. Lipinski, C., Lombardo, F., Dominy, B. & Feeney, P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25 (1997).
2. Drews, J. Genomic sciences and the medicine of tomorrow. Nature Biotechnol. 14, 1516-1518 (1996).
3. Drews, J. & Ryser, S. Classic drug targets. Nature Biotechnol. 15, 1318-1319 (1997).
4. Drews, J. Drug discovery: a historical perspective. Science 287, 1960-1964 (2000).
5. Bailey, D., Zanders, E. & Dean, P. The end of the beginning for genomic medicine. Nature Biotechnol. 19, 207-209 (2001).
6. Apweiler, R. et al. The InterPro database, an integrated documentation resource for protein families, domains and functional sites. Nucleic Acids Res. 29, 37-40 (2001).
7. Proteome Analysis Database [online], (version analysed with release date 29 Oct 01) http://www.ebi.ac.uk/proteome/ (2001).
8. Lander, E. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
9. Venter, J. C. et al. The sequence of the human genome. Science 291, 1304-1351 (2001).
10. Tweeddale, H., Notley-McRobb, L. & Ferenci, T. Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ('metabolome') analysis. J. Bacteriol. 180, 5109-5119 (1998).
11. Fiehn, O. et al. Metabolite profiling for plant functional genomics. Nature Biotechnol. 18, 1157-1161 (2000).
12. Raamsdonk, L. et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature Biotechnol. 19, 45-50 (2001).
13. Claverie, J.-M. What if there are only 30,000 human genes? Science 291, 1255-1257 (2001).
14. Walke, D. W. et al. In vivo drug target discovery: identifying the best targets from the genome. Curr. Opin, Biotechnol. 12, 626-631 (2001)
15. Lehman Brothers. The Fruits of Genomics (Lehman Brothers, 2001).
16. Rubin, G. Comparative genomics of the eukaryotes. Science 24, 2204-2215 (2000).